![John Borgeson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Borgeson
Finansdirektör/CFO på
KODIAK SCIENCES INC.
Förmögenhet: 8 M $ per 2026-06-30
Profil
John A. Borgeson is currently Chief Financial Officer, Secretary & Executive VP at Kodiak Sciences, Inc. since 2016.
Formerly, Mr. Borgeson was Vice President-Finance at Pfizer Inc. from 2007 to 2010, an Auditor at Ernst & Young LLP, and Chief Financial Officer at Solstice Biologics LLC.
Education includes an MBA from Rochester Institute of Technology and an MBA from The University At Buffalo School of Management.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
KODIAK SCIENCES, INC. 0,34 % | 2026-06-04 | 211 930 ( 0,34 % ) | 8 M $ | 2026-06-30 |
Aktiva positioner av John Borgeson
| Företag | Position | Start |
|---|---|---|
| KODIAK SCIENCES INC. | Finansdirektör/CFO | 2016-01-01 |
Tidigare kända positioner av John Borgeson
| Företag | Position | Slut |
|---|---|---|
| PFIZER INC. | Företagsledare/Principal | 2010-01-01 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Revisor | - |
Solstice Biologics LLC
 Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Develops cell-permeable RNAi pro-drugs | Finansdirektör/CFO | - |
John Borgesons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
99
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Solstice Biologics LLC
Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Develops cell-permeable RNAi pro-drugs | Health Technology |
Rochester Institute of Technology
 Rochester Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University At Buffalo School of Management
 The University At Buffalo School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kodiak Sciences, Inc.
 Kodiak Sciences, Inc. BiotechnologyHealth Technology Develops novel therapies for the treatment of retinal disease | Health Technology |
![\"G](\"https://www.zonebourse.com/images/ImagesTagged/GD/2026/google/Google__G__logo.svg\"){kind=logo}
Välj MarketScreener 
